| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000041921 |
| Receipt No. | R000047845 |
| Scientific Title | Risk factors for postoperative nausea and vomiting in patients who underwent catheter ablation |
| Date of disclosure of the study information | 2020/12/01 |
| Last modified on | 2020/09/28 (Ver. 1) |
| Basic information | ||
| Public title | Risk factors for postoperative nausea and vomiting in patients who underwent catheter ablation | |
| Acronym | Risk factors for postoperative nausea and vomiting in patients who underwent catheter ablation | |
| Scientific Title | Risk factors for postoperative nausea and vomiting in patients who underwent catheter ablation | |
| Scientific Title:Acronym | Risk factors for postoperative nausea and vomiting in patients who underwent catheter ablation | |
| Region |
|
|
| Condition | ||
| Condition | patients who underwent catheter ablation in operation rooom | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Cases in which ablation has been performed in the operating room will be selected. Among the selected cases, we will divide them into two groups, PONV and non-PONV, and study the perioperative factors. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Investigate risk factors for the development of PONV within 24 hours after ablation surgery |
| Key secondary outcomes | Identify the relationship between PONV and health care resources, including length of stay, within 24 hours after surgery |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients who underwent ablation
2) Patients under general anesthesia for the above operations 3) Age: 18 years and older 4) Gender: any gender 5) By inpatient/outpatient category: inpatients 6) No questions about the American Society of Anesthesiologists (ASA) systemic classification. |
|||
| Key exclusion criteria | 1) Patients with communication difficulties due to dementia, mental illness, etc.
2) Emergency surgery cases 3) Cases in which extubation was not performed in the operating room 4) Other patients whose participation in the study is judged to be problematic by the principal investigator or research co-investigator. |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Saga University Hospital | ||||||
| Division name | Anesthesiology and Critical Care Medicins | ||||||
| Zip code | 849-8501 | ||||||
| Address | 5-1-1, Nabeshima-cho, Saga City, Saga Prefecture | ||||||
| TEL | 0952343370 | ||||||
| e6580@cc.saga-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Saga University Hospital | ||||||
| Division name | Anesthesiology and Critical Care Medicins | ||||||
| Zip code | 849-8501 | ||||||
| Address | 5-1-1, Nabeshima-cho, Saga City, Saga Prefecture | ||||||
| TEL | 0952343370 | ||||||
| Homepage URL | |||||||
| e6580@cc.saga-u.ac.jp | |||||||
| Sponsor | |
| Institute | Saga University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saga University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Saga University Hospital |
| Address | 5-1-1, Nabeshima-cho, Saga City, Saga Prefecture |
| Tel | 0952343400 |
| e6580@cc.saga-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047845 |